
Sensible Biotechnologies
Unlocking the next generation of mRNA medicines
Oxford, GB
Synthetic BiologyBiotechManufacturingTherapeuticsBiotechnology
The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.
Meet the team2
The people behind Sensible Biotechnologies
Miroslav Gasparek
Founder
Marian Kupculak
Founder